COVID-19: Yole’s analysts point out the impacts on the bioMEMS industry


  • The bioMEMS device market is expected to reach US$6.3 billion in 2025 with a CAGR 19-25 of 9.2%.
  • Undoubtedly, healthcare is still a source of a strong interest for MEMS devices.
  • Is the new rule for the bioMEMS industry: one player, one MEMS device?
  • The TOP 5 bioMEMS companies are manufacturers of pressure sensors and microfluidic chips, led by TE Connectivity, Amphenol and Boehringer Ingelheim…
  • COVID-19 outbreak:
    -  After combining the positive and negative impacts, the overall bioMEMS market is expected to show a 12.4% growth from 2019 to 2020.
    The impact of COVID-19 on bioMEMS market dynamics will not be the same from one application to another. The impact of COVID-19 on bioMEMS market dynamics will not be the same from one application to another.
    In the medium to long term, connected wearables and point of care medical devices should find more interest from healthcare providers thanks to the impact of Covid-19 on healthcare sector (caregivers and patient behavior). In the medium to long term, connected wearables and point of care medical devices should find more interest from healthcare providers thanks to the impact of Covid-19 on healthcare sector (caregivers and patient behavior).

“It is now a reality, the world, and particularly the healthcare sector, will have experienced a before, and an after, the COVID-19 outbreak.” asserts Jérôme Mouly, Senior Technology & Market Analyst and Business Developer at Yole Développement (Yole).“The pandemic has strongly hit the medical devices and IVD sector with an impact on sales as well as on applications and usage. However, the impact is slightly different in the healthcare sector than in other domains, such as consumer or automotive markets. Moreover, it is highly application-related”.
BioMEMS devices, defined as MEMS sensors and microfluidic devices integrated into medical devices and used for IVD and life sciences, are reflecting the market demand for the products in which they are integrated.
Indeed, the global bioMEMS market was worth US$3.7 billion in 2019 and is expected to reach US$6.3 billion in 2025 with a CAGR between 2019 and 2025 of 9.2% in revenue. The microfluidic chips market represents 85% of the market due to the huge market for polymer-based microfluidic chips. This is followed by the pressure sensor market.
In volume, the highest growth expected on the next five years is for MUT for medical imaging and IVUS, and for inertial MEMS (especially IMU ) related to fall detection and activity tracking.
The larger market segments using mainly microfluidic chips are pharmaceutical research and IVD testing.
The key drivers for the use of MEMS and microfluidic technologies are:
•  IT environment and telecommunication (5G network is one major contributor).
•  Cost pressure on healthcare: development of systems for home care, point of care and medical wearables to monitor patients out of hospital.
•  The contribution of advanced technologies to reduced power and miniaturized systems.

In this context, Yole investigates disruptive technologies and related markets in depth, in order to point out the latest innovations and to underline the business opportunities. In this regard, the Photonic & Sensing team delivers three dedicated reports to highlight the latest technical and market trends: BioMEMS Market and Technology, Point-of-Need 2020 – Including PCR-Based Testing, and Thermal Imagers and Detectors 2020 – COVID-19 Outbreak Impact – Preliminary.
Released today, the BioMEMS market and technology report gives a comprehensive overview of MEMS devices, including pressure sensors, MEMS microphones, inertial MEMS, microfluidic chips, microdispensers, optical MEMS, MUT, flowmeters… All of them are integrated or used in the life sciences and healthcare domains. This study provides the latest major information and key facts of the bioMEMS industry.
Taking into account the COVID-19 impacts at the sensor and end system level, analysts examine the bioMEMS market and propose a complete review of the industry and future trends. Including market forecasts, main player market shares, ecosystem, supply chain and market and technology trends, this report provides a detailed description of this industry. This report also identifies the emerging bioMEMS sensors: design, integration, and usage challenges.
What are the economic and technological challenges? What are the impacts of COVID-19 on the bioMEMS industry in both the short and long term? What are the key drivers? Who are the suppliers to watch, and what innovative technologies are they working on? Yole presents today its vision of the bioMEMS industry.

As analyzed by Yole’s team in the new BioMEMS market and technology report, acute respiratory symptoms of COVID-19 generated a sudden need for interventional equipment like ventilators, and influenced the requirements for MEMS pressure sensors and flowmeters. There was also a huge demand for non-contact thermometers from Asia, particularly China. IR thermometers play a big role in patient monitoring at hospitals and for implementation of preventive policies in public areas like airports or stations. Thus, IR thermopile shipments are increasing rapidly with a tremendous 90.5% growth expected from 2019 to 2020. In the IVD domain, many diagnostics companies started development projects to provide as soon as possible either rapid point-of-care tests or high-throughput tests for use in the central lab. Some of these tests are built on microfluidic chips, as well as the DNA sequencing flow cells that are useful tools to study the virus and hopefully develop a treatment or vaccine.
“Apart from the requirements of hospitals and central labs, the pandemic has also altered patients’ behavior towards more telemedicine and home consultation to limit physical contact”explains Sébastien Clerc, Technology & Market Analyst, Microfluidics, Sensing & Actuating at Yole. “It accelerated adoption of home monitoring and point of care devices”.
One example is the Butterfly IQ probe which uses MUT technology, allowing flexible use by nurses or GPs for early diagnostics at the patient’s side. The technology and cost analysis company System Plus Consulting analyses in depth the first CMUT on silicon bonded with an ASIC die for medical ultrasound, in the dedicated structural, process & cost report, Butterfly Network iQ CMUT Sensor.
In the medium to long term, wearables and connected medical devices should find more interest from healthcare systems.
Definitely, the impact of COVID-19 on bioMEMS market dynamics will not be the same from one application to another. Increased demands for respiratory systems will increase the need for bioMEMS for the duration of the pandemic, while the requirement for remote connected medical devices will be intensified in the long term.

Efforts to improve MEMS device reliability, measurement accuracy and compliance with healthcare regulations (requested by the integrators at the system level) require strong skills and experience in order to serve the healthcare sector. Emerging bioMEMS like microneedles, MUT or optical MEMS devices have sometimes complex designs or are otherwise highly challenging for integration when the use case is not itself imposing other barriers.
According to Jérôme Mouly from Yole:
“Analysis of the players and supply chain show that bioMEMS makers are often focused on a single MEMS device, sometimes two device types. Most of the Top bioMEMS players also serve the industrial domain, having experience with high-end and highly regulated applications. MEMS foundries are playing a big role, working on high added value projects, developing key process steps like PZT deposition or CMOS-MEMS integration”.
A new wave of players is also becoming increasingly involved, as the healthcare sector is currently moving to more preventive and personalized care: consumer MEMS companies are strongly interested in serving consumer healthcare applications, where volumes could be attractive and regulations less strict. However, the frontier between regulated and non-regulated markets is blurred.
Along with the TOP bioMEMS players, newcomers are starting to deliver bioMEMS products in the healthcare sector, and stronger bioMEMS players are emerging through recent Mergers and Acquisitions…
A detailed analysis of the supply chain is available in the bioMEMS report presented by Yole.

All year long, System Plus Consulting and Yole Développement combine their expertise and deep understanding of the markets and disruptive technologies to publish numerous reports. In addition, our experts realize various key presentations and organize key conferences. Throughout the year, discover the numerous med-tech-related reports including the BioMEMS, the Point-of-Need Testing, the Thermal Imagers and Detectors and the Butterfly Network ones. Make sure to be aware of the latest news coming from the industry and get an overview of our activities, including interviews with leading companies and more on i-Micronews... Stay tuned!

CAGR: Compound Annual Growth Rate
MEMS: Micro Electro-Mechanical Systems
IVD: In-Vitro Diagnostics
MUT : Micromachined Ultrasound Transducers
IMU : Inertial Measurement Unit
IR: Infra Red
IVD: In Vitro Diagnostic
GP: General Practitioners
ASIC: Application Specific Integrated Circuit
PZT: Lead Zirconate Titanate